TDP43 can regulate the alternative splicing of CD44 pre-mRNA via binding to a UG repeat sequence between CD44 pre-mRNA variant exon 10 and standard exon 6, ultimately facilitating the stemness of breast cancer stem cells (51). This evidence concerns the gene CD44 and breast cancer.